Top Page
Althea Group Holdings Ltd.
(Sydney:AGH)
Althea Group Holdings Ltd. (AGH) vs. iShares MSCI Australia ETF (EWA)
Althea Group Holdings Ltd. Business Overview & Revenue Model
Althea Group Holdings Ltd. Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.04M | 15.49M | 29.40M | 24.82M | 20.08M | 11.07M |
| Gross Profit | 6.32M | 7.47M | 17.46M | 12.62M | 9.29M | 5.29M |
| EBITDA | -2.13M | -2.40M | -23.48M | -10.44M | -9.32M | -13.03M |
| Net Income | -4.94M | -8.35M | -32.06M | -13.72M | -12.12M | -15.05M |
Balance Sheet | ||||||
| Total Assets | 20.49M | 20.49M | 23.65M | 48.34M | 56.56M | 53.91M |
| Cash, Cash Equivalents and Short-Term Investments | 528.00K | 528.00K | 331.00K | 3.87M | 6.21M | 6.39M |
| Total Debt | 5.19M | 5.19M | 6.54M | 4.85M | 5.14M | 4.05M |
| Total Liabilities | 21.06M | 21.06M | 23.34M | 18.57M | 15.12M | 11.22M |
| Stockholders Equity | -574.00K | -574.00K | 314.00K | 29.77M | 41.45M | 42.70M |
Cash Flow | ||||||
| Free Cash Flow | -5.71M | -8.01M | -4.83M | -7.78M | -10.04M | -12.85M |
| Operating Cash Flow | -5.06M | -7.09M | -4.39M | -6.29M | -9.05M | -10.45M |
| Investing Cash Flow | 1.08M | 978.00K | 2.29M | -1.49M | -982.00K | -2.40M |
| Financing Cash Flow | 7.42M | 6.31M | -1.44M | 5.55M | 9.89M | 9.18M |
Althea Group Holdings Ltd. Technical Analysis
Althea Group Holdings Ltd. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
46 Neutral | $10.55M | ― | -401.36% | ― | -26.49% | 61.72% | |
44 Neutral | ― | ― | ― | ― | -3.82% | 79.24% | |
41 Neutral | AU$19.03M | ― | -218.38% | ― | -47.30% | 82.53% | |
39 Underperform | AU$4.26M | 16.00 | ― | ― | 69.59% | ― |
Althea Group Holdings Ltd. Corporate Events
Althea Group Holdings Ltd. announced the issuance of 5,000,000 unquoted options set to expire on August 1, 2027, with an exercise price of $0.03. This move is part of a previously announced transaction and is not intended to be quoted on the ASX, potentially impacting the company’s capital structure and offering strategic flexibility for future growth.
Althea Group Holdings Ltd. has announced the issuance of 13,064,228 performance rights as part of an employee incentive scheme. These unquoted securities are not intended to be listed on the ASX, and this move is likely aimed at motivating and retaining key personnel, which could have implications for the company’s operational efficiency and competitive positioning in the market.
Althea Group Holdings Ltd. has announced the issuance of 20,056,731 ordinary fully paid securities on August 1, 2025, as part of previously announced transactions. This development is expected to enhance the company’s market presence by increasing its share liquidity and potentially attracting more investors, thereby strengthening its position in the industry.
Althea Group Holdings Ltd. has announced the issuance of 2,834,855 fully paid ordinary securities on August 1, 2025. This move is part of a previously announced transaction, indicating a strategic step to enhance the company’s market presence and potentially increase its capital base, which could have significant implications for its stakeholders and market positioning.
Althea Group Holdings Ltd. has announced a proposed issue of securities, including 5,000,000 options and 100 fully paid ordinary shares, with a proposed issue date of August 1, 2025. This strategic move is expected to enhance the company’s capital structure, potentially strengthening its market position and providing additional resources to support its growth and operational objectives.
Althea Group Holdings Ltd. has announced a proposed issue of 2,834,855 ordinary fully paid securities, with the issuance date set for August 1, 2025. This move is part of a placement or other type of issue, potentially impacting the company’s market positioning by increasing its capital base and enhancing its ability to invest in growth opportunities.
Althea Group Holdings Ltd. has announced a prospectus offering involving two main components: a Cleansing Offer and an Options Offer. The Cleansing Offer aims to issue up to 100 shares at A$0.10 each to raise a nominal amount of $10, primarily to remove trading restrictions on the sale of shares issued in August 2025. The Options Offer involves issuing 5 million new options to ensure compliance with the Corporations Act, allowing the sale of these options and any shares resulting from their exercise. This strategic move is intended to facilitate trading flexibility and compliance with regulatory requirements, potentially impacting the company’s market operations and investor relations.
Althea Group Holdings Ltd. has released its June 2025 Quarterly Activities & Cashflow Report, detailing its financial and operational performance. The report highlights the company’s activities in Canada and the USA, indicating strategic developments and financial outcomes that could influence its market positioning and stakeholder interests.
Althea Group Holdings Ltd announced the resignation of its CEO and founder, Joshua Fegan, who played a crucial role in establishing the company’s presence in the medicinal cannabis and THC beverage markets. Barry Katzman, with extensive experience in the North American beverage industry, has been appointed as the Interim CEO to lead the company through its next growth phase, particularly in the THC beverage sector in Canada and the US.
Althea Group Holdings Ltd. announced the cessation of 2,675,000 securities due to the expiry of options or other convertible securities without exercise or conversion. This announcement may impact the company’s capital structure and could influence investor perceptions regarding the company’s financial strategies and future growth plans.
Althea Group Holdings Ltd.’s Canadian subsidiary, Peak Processing Solutions, has launched its own-brand manufactured (OBM) strategy with the introduction of Snap Back, a premium rosin-infused THC beverage line. This strategic move marks a significant milestone as it expands Peak’s operations from B2B manufacturing to direct-to-retail sales, enhancing utilization of existing capacity and creating a new revenue stream. The initial product, Strawberry Vanilla Cream, is now available in Ontario and Manitoba, with plans to expand into other provinces. This development positions Peak Canada to capture additional market share in the fast-growing premium THC beverage segment, leveraging its strong relationships with provincial buyers and maintaining operational efficiency.
Althea Group Holdings Ltd. has announced a proposed issue of 20,056,731 ordinary fully paid securities, with the issue date set for July 21, 2025. This move is part of a strategic effort to raise capital, potentially enhancing the company’s financial flexibility and supporting its growth initiatives in the competitive medicinal cannabis market.
Althea Group Holdings Ltd has completed the sale of certain assets of its wholly owned subsidiary, Althea Company Pty Ltd, for $1 million in cash. Following the sale, the subsidiary will undergo Voluntary Administration to resolve its remaining obligations, a move that is not expected to impact AGH’s operations. AGH continues to focus on expanding its North American THC beverage business, Peak Processing Solutions, to capitalize on the growing market in the United States and Canada.
Althea Group Holdings Ltd has executed a definitive Asset Sale Agreement to sell certain assets of its subsidiary, Althea Company Pty Ltd, to Tasmanian Botanics Pty Ltd. This strategic move allows AGH to focus entirely on its North American THC-infused beverage operations under the Peak Processing Solutions brand, marking a significant shift in the company’s operational focus. The transaction, valued at $1.0 million with additional profit-sharing terms, will help strengthen AGH’s balance sheet through targeted debt repayment, without impacting its board or executive management.
Althea Group Holdings Limited announced a change in its head office telephone number to +61 3 7044 2936. This update, made in accordance with ASX Listing Rule 3.14, does not affect any other contact details. The change is a minor operational update and is unlikely to have significant implications for stakeholders or the company’s market positioning.
Althea Group Holdings Ltd. has announced a strategic shift by disposing of its pharmaceutical assets to concentrate on the high-growth potential of THC beverages. This move aligns with the company’s focus on expanding its market presence in the U.S. and leveraging its Canadian subsidiary, Peak, which is noted for its scalable business model and high barriers to entry. The strategic realignment is expected to enhance Althea’s industry positioning and provide significant opportunities for growth, impacting stakeholders positively by focusing on a promising segment of the cannabis market.
Althea Group Holdings Limited is set to host a live webinar to discuss its strategic decision to divest its pharmaceutical assets and focus on the global THC-infused beverage market. This move aims to capitalize on the high demand in this segment, particularly in North America, positioning AGH as a leader in this space.
Althea Group Holdings Ltd has appointed Brian Mbesha as its new Chief Financial Officer, effective June 9, 2025. Mr. Mbesha, with over two decades of experience in senior finance roles across North America, will be based at the company’s North American headquarters in Windsor, Ontario. His extensive expertise in financial systems optimization, cost control, and operational efficiency is expected to significantly contribute to AGH’s growth and transformation efforts. The appointment is anticipated to enhance the company’s strategic and operational capabilities as it continues to scale its business in the competitive THC beverage market.
Althea Group Holdings Ltd has announced the withdrawal of its FY25 financial guidance following the sale of its pharmaceutical assets to Tasmanian Botanics Pty Ltd. This strategic divestment allows the company to concentrate its resources on the high-growth North American THC-infused beverage market, where its subsidiaries, Peak Canada and Peak USA, are poised to lead. The move signifies a pivotal shift in AGH’s business strategy, aligning its operations with its evolving focus on the THC beverage sector.
Althea Group Holdings Ltd. has announced the sale of its pharmaceutical assets to Tasmanian Botanics Pty Ltd for $1 million, along with a revenue-sharing arrangement on residual inventory sales. This strategic divestment allows AGH to concentrate on the booming THC-infused beverage market in North America, leveraging its expertise and proprietary technology to capitalize on growing consumer demand. The transaction aligns with AGH’s vision to enhance shareholder value by focusing on high-growth, lower-risk product categories, and ensures continuity of care for Althea’s existing patients and prescribers.